Megan Montoya is pursuing her Ph.D. in Biomedical Sciences at the University of California, San Francisco, who is interested in creating myeloid-targeted immunotherapies for Glioblastoma. She earned her B.S. in Molecular and Cellular Biology (Minors in Biochemistry, Microbiology, and French) from the University of Arizona in 2018. She had her research Internship about tRNA intron splicing in Trypanosoma brucei at the University of South Bohemia in České Budějovice, in 2016 and her research Internship about how the GLI-OPN axis promotes an aggressive subtype of pancreatic ductal adenocarcinoma at the University of California, San Francisco, in 2017.